Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease
Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: A Landmark Evidence-Based Guideline In the ever-evolving landscape of inflammatory bowel disease (IBD) management, biologic therapies have emerged as transformative agents that...
Read moreDetails






















